First Time Loading...

Chenguang Biotech Group Co Ltd
SZSE:300138

Watchlist Manager
Chenguang Biotech Group Co Ltd Logo
Chenguang Biotech Group Co Ltd
SZSE:300138
Watchlist
Price: 9.26 CNY 1.65% Market Closed
Updated: Apr 26, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Chenguang Biotech Group Co Ltd

Wall Street analysts forecast Chenguang Biotech Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Chenguang Biotech Group Co Ltd is 19.05 CNY with a low forecast of 15.98 CNY and a high forecast of 27.3 CNY.

Lowest Forecast
Wall Street Target
15.98 CNY
73% Upside
Average Forecast
Wall Street Target
19.05 CNY
106% Upside
Highest Forecast
Wall Street Target
27.3 CNY
195% Upside
Lowest
Price Target
15.98 CNY
73% Upside
Average
Price Target
19.05 CNY
106% Upside
Highest
Price Target
27.3 CNY
195% Upside
Chenguang Biotech Group Co Ltd Competitors:
Price Targets
FLOB
Floridienne SA
33% Upside
2004
Showa Sangyo Co Ltd
7% Downside
600073
Shanghai Maling Aquarius Co Ltd
16% Upside
603317
Sichuan Teway Food Group Co Ltd
21% Upside
FLOB
Floridienne SA
33% Upside
2004
Showa Sangyo Co Ltd
7% Downside
600073
Shanghai Maling Aquarius Co Ltd
16% Upside
603317
Sichuan Teway Food Group Co Ltd
21% Upside
2002
Nisshin Seifun Group Inc
32% Upside
X
300106
Xinjiang Western Animal Husbandry Co Ltd
233% Upside
Y
1230
Yashili International Holdings Ltd
43% Downside
G
000529
Guangdong Guanghong Holdings Co Ltd
188% Upside

Revenue
Forecast

Revenue Estimate
Chenguang Biotech Group Co Ltd

For the last 8 years the compound annual growth rate for Chenguang Biotech Group Co Ltd's revenue is 23%. The projected CAGR for the next 3 years is 14%.

23%
Past Growth
14%
Estimated Growth
Estimates Accuracy
1%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Chenguang Biotech Group Co Ltd

For the last 8 years the compound annual growth rate for Chenguang Biotech Group Co Ltd's operating income is 41%. The projected CAGR for the next 3 years is 12%.

41%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-12%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Chenguang Biotech Group Co Ltd

For the last 8 years the compound annual growth rate for Chenguang Biotech Group Co Ltd's net income is 45%. The projected CAGR for the next 3 years is 17%.

45%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Chenguang Biotech Group Co Ltd's stock price target?
Price Target
19.05 CNY

According to Wall Street analysts, the average 1-year price target for Chenguang Biotech Group Co Ltd is 19.05 CNY with a low forecast of 15.98 CNY and a high forecast of 27.3 CNY.

What is Chenguang Biotech Group Co Ltd's Revenue forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Chenguang Biotech Group Co Ltd's revenue is 23%. The projected CAGR for the next 3 years is 14%.

What is Chenguang Biotech Group Co Ltd's Operating Income forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Chenguang Biotech Group Co Ltd's operating income is 41%. The projected CAGR for the next 3 years is 12%.

What is Chenguang Biotech Group Co Ltd's Net Income forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Chenguang Biotech Group Co Ltd's net income is 45%. The projected CAGR for the next 3 years is 17%.

ALPHA SPREAD
Join more than 131,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.